You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The RT-PCR-based tests are designed to detect SARS-CoV-2 nucleic acid in a range of upper and lower respiratory specimens including nasal swabs and sputum.
Vela anticipates CE-IVD marking for an automated version of its test, and JN Medsys has received authorization for its test in Singapore and the Philippines.
The test is designed for the detection of nucleic acid from SARS-CoV-2 in nasopharyngeal, oropharyngeal, nasal, and mid-turbinate nasal swab specimens as well as sputum.
Aytu has committed to purchasing at least 1.25 million tests within the first three months of the deal, including 500,000 tests immediately.
The agreement reflects Oncocyte's strategy to establish distribution partners with existing oncology channels to extend the reach of its tests globally.
The platform's portability and internet connectivity could enable it to locate and track the distribution of disease in real time, its developers said.
Fosun Pharma said its kit detects novel coronavirus RNA targeting the ORF1ab, N, and E genes, and it can test 96 samples within two hours.
The funds will be used to launch new products in the US, as well as for R&D activities including the development of polygenic risk tests with partner TGen.
The test is a probe-based reverse transcription PCR test for detecting the coronavirus by targeting conserved regions of its genome.
The test is designed to detect nucleic acid from SARS-CoV-2 in upper respiratory specimens such as oropharyngeal swabs and nasopharyngeal swabs.